Custom Antibody Market
Global Custom Antibody Market Research By Service (Antibody Development, Antibody Fragmentation & Labeling, and Antibody Production & Purification), By Type (Monoclonal Antibodies, Recombinant Antibodies, Polyclonal Antibodies and Other), By Research Area (Oncology, immunology, infectious diseases, neurobiology, cardiovascular diseases and Other) and End-User (pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations) Forecast 2021-2027
The global custom antibody market is growing at a considerable CAGR of 10.0% during the forecast period. Rising emphasis on therapeutic antibodies and immense pipeline drugs is considered as the prime factors affecting and driving the market. The increasing concerns associated with catalog antibodies along with a growing number of collaborations between industries are also estimated to be the key factors that are contributing significantly towards the growth of the market. However, the involvement of high cost along with time-intensive antibody development process and the existence of alternative antibodies is the major factor constraints that are hindering the growth of the global custom antibody market across the globe.
Moreover, the emerging focus on rising demand in protein therapeutics associated with personalized medicine and the growing focus on biomarker discovery are the key factors that are creating opportunities in the market. New product launches in the market are likely to drive the growth of the global custom antibody market. For instance, in July 2020, for the purpose of developing and doing commercialization of novel custom antibodies that will support the acceleration of cancer research a new partnership was being announced by Cancer Research UK and Abcam plc.
Impact of COVID-19 Pandemic on the Global Custom Antibody Market
The global custom antibody market is hardly hit by the COVID-19 pandemic since December 2019. The COVID-19 pandemic in the major economies had brought a lot of disruption. However, the activities associated with research work had been increased for vaccine purposes in academic & research institutes and pharmaceutical & biotechnology companies. Additionally, the funding for research and development related to antibodies which includes custom antibodies as well had also increased which is anticipating the growth of the market.
Segmental Outlook
The global custom antibody market is segmented based on service, type, research area, and end-user. Based on service, the market is segmented into antibody development, antibody fragmentation & labeling, and antibody production & purification. By type, the market is segmented into monoclonal antibodies, recombinant antibodies, and polyclonal antibodies, and other. Further, based on research area the market is segmented into oncology, immunology, infectious diseases, neurobiology, cardiovascular diseases, and other. Based on end-user the market is segmented into pharmaceutical & biotechnology companies, academic & research institutes, and contract research organizations.
Global Custom Antibody Market Share by Type 2020 (%)
Based on the segment type, the monoclonal antibodies are having a significant share in the market. Monoclonal antibodies are utilized for the treatment of several diseases which even include some types of cancer. For the purpose of making monoclonal antibody the researchers have to recognize the correct antigen to attack. Additionally, when compared with other antibodies, the monoclonal antibodies are considered to be high specificity and selectivity.
Regional Outlooks
The global custom antibody market is analyzed based on the geographical regions that are contributing significantly towards the growth of the market. Based on the geography, the market is segmented into North America, Europe, Asia-Pacific, and the Rest of the World. North America held a considerable share in 2020 in the global custom antibody market. Some factors that are boosting the market growth in North America are rising investment in drug designs that are structured based, evolving antibody-based therapeutics across the region along with the existence of a large number of players in the region.
Global Custom Antibody Market, by Region 2021-2027
Asia-Pacific will have Considerable Growth in the Global Custom Antibody Market
Asia-Pacific region is expected to witness significant growth opportunities for the market. Increasing investments by government across the region is likely to drive the growth of the regional market. Additionally, key market companies expanding their reach with their new bringing and increasing research associated with biotechnology in this region, especially in South Korea, China, and India are also supporting the growth of the market.
Market Player Outlook
Key players of the global custom antibody market are Bio-Rad Laboratories, Inc., Cell Signaling Technology, Inc., GenScript, Thermo Fisher Scientific Inc., and Merck KgaA. To survive in the market, these players adopt different marketing strategies such as product launches and mergers and acquisitions. For instance, in March 2020, Abcam plc. had done the acquisition of one of the Oregon-based life sciences research tools firm of Eugene, named Marker Gene Technologies (MGT) in order to enhance its portfolio.
In October 2019, Proteogenix had introduced new human and rabbit antibody libraries LiAb-SFMAX (3×1010 clones) in order to develop the diversity along with comprising of the repertoire of 364 healthy donors from 5 different ethnic groups. This could be utilized as one of the effective approaches for the generation of therapeutic antibodies. The LiAb-SFMAX combing with the phage display will support in obtaining clinical candidates without the requirement of lengthy along with high-priced humanization process. Additionally, LiAb-SFRab (1×1010 clones) rabbit antibody had also been made for maximized diversity having a complete repertoire of 40 healthy rabbits from 4 different breeds. These antibodies are considered to be worthy of traditional mouse antibodies as with the presence of its affinity, sensitivity, specificity in order to do analytical applications that include ELISA, Western Blot, Immunohistochemistry, Immunoprecipitation.
In August 2018, AMSBIO collaborated with the University of Strathclyde located in Glasgow in UK for combing the platform of microfluidic lab-on-a-chip technology along with physiologically relevant 3D spheroids for cancer research.
The Report Covers
• Market value data analysis of 2020 and forecast to 2027.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the global custom antibody market based on the availability of data, information related to new product launches, and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where in the market.
1. Report Summary
• Current Industry Analysis and Growth Potential Outlook
• Impact of COVID-19 on the Global Custom Antibody Industry
• Recovery Scenario of Global Custom Antibody Industry
1.1. Research Methods and Tools
1.2. Market Breakdown
1.2.1. By Segments
1.2.2. By Geography
2. Market Overview and Insights
2.1. Scope of the Report
2.2. Analyst Insight & Current Market Trends
2.2.1. Key Findings
2.2.2. Recommendations
2.2.3. Conclusion
3. Competitive Landscape
3.1. Key Company Analysis
3.1.1. Overview
3.1.2. Financial Analysis
3.1.3. SWOT Analysis
3.1.4. Recent Developments
3.2. Key Strategy Analysis
3.3. Impact of Covid-19 on Key Players
4. Market Determinants
4.1. Motivators
4.2. Restraints
4.3. Opportunities
5. Market Segmentation
5.1. Global Custom Antibody Market by Service
5.1.1. Antibody Development
5.1.2. Antibody Fragmentation & Labeling
5.1.3. Antibody Production & Purification
5.2. Global Custom Antibody Market by Type
5.2.1. Monoclonal Antibodies
5.2.2. Recombinant Antibodies
5.2.3. Polyclonal Antibodies
5.2.4. Other
5.3. Global Custom Antibody Market by Research Area
5.3.1. Oncology
5.3.2. Immunology
5.3.3. Infectious Diseases
5.3.4. Neurobiology
5.3.5. Cardiovascular Diseases
5.3.6. Other
5.4. Global Custom Antibody Market by End-User
5.4.1. Pharmaceutical & Biotechnology Companies
5.4.2. Academic & Research Institutes
5.4.3. Contract Research Organizations
6. Regional Analysis
6.1. North America
6.1.1. United States
6.1.2. Canada
6.2. Europe
6.2.1. UK
6.2.2. Germany
6.2.3. Italy
6.2.4. Spain
6.2.5. France
6.2.6. Rest of Europe
6.3. Asia-Pacific
6.3.1. China
6.3.2. India
6.3.3. Japan
6.3.4. South Korea
6.3.5. Rest of Asia-Pacific
6.4. Rest of the World
7. Company Profiles
7.1. AMSBIO
7.2. Abbiotec, Inc.
7.3. Abcam plc.
7.4. Bio-Rad Laboratories, Inc.
7.5. BioLegend, Inc.
7.6. Boster Biological Technology
7.7. Cell Signaling Technology, Inc.
7.8. Creative Diagnostics
7.9. Capralogics, Inc.
7.10. GenScript
7.11. Giotto Biotech
7.12. Innovagen AB
7.13. Merck KGaA
7.14. ProMab
7.15. Proteogenix
7.16. ProSci
7.17. RayBiotech Life, Inc.
7.18. Rockland Immunochemicals, Inc.
7.19. Sino Biological Inc.
7.20. Thermo Fisher Scientific Inc.
1. GLOBAL CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS, 2020-2027 ($ MILLION)
2. GLOBAL CUSTOM ANTIBODY MARKET BY SERVICE, 2020-2027 ($ MILLION)
3. GLOBAL ANTIBODY DEVELOPMENT MARKET BY REGION, 2020-2027 ($ MILLION)
4. GLOBAL ANTIBODY FRAGMENTATION & LABELING MARKET BY REGION, 2020-2027 ($ MILLION)
5. GLOBAL ANTIBODY PRODUCTION & PURIFICATION MARKET BY REGION, 2020-2027 ($ MILLION)
6. GLOBAL CUSTOM ANTIBODY MARKET BY TYPE, 2020-2027 ($ MILLION)
7. GLOBAL MONOCLONAL ANTIBODIES MARKET BY REGION, 2020-2027 ($ MILLION)
8. GLOBAL RECOMBINANT ANTIBODIES MARKET BY REGION, 2020-2027 ($ MILLION)
9. GLOBAL POLYCLONAL ANTIBODIES MARKET BY REGION, 2020-2027 ($ MILLION)
10. GLOBAL OTHER MARKET BY REGION, 2020-2027 ($ MILLION)
11. GLOBAL CUSTOM ANTIBODY MARKET BY RESEARCH AREA, 2020-2027 ($ MILLION)
12. GLOBAL ONCOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
13. GLOBAL IMMUNOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
14. GLOBAL INFECTIOUS DISEASES MARKET BY REGION, 2020-2027 ($ MILLION)
15. GLOBAL NEUROBIOLOGY MARKET BY REGION, 2020-2027 ($ MILLION)
16. GLOBAL CARDIOVASCULAR DISEASES MARKET BY REGION, 2020-2027 ($ MILLION)
17. GLOBAL OTHER MARKET BY REGION, 2020-2027 ($ MILLION)
18. GLOBAL CUSTOM ANTIBODY MARKET BY END-USER, 2020-2027 ($ MILLION)
19. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET BY REGION, 2020-2027 ($ MILLION)
20. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET BY REGION, 2020-2027 ($ MILLION)
21. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY REGION, 2020-2027 ($ MILLION)
22. GLOBAL CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY GEOGRAPHY, 2020-2027 ($ MILLION)
23. NORTH AMERICAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
24. NORTH AMERICAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY SERVICE, 2020-2027 ($ MILLION)
25. NORTH AMERICAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
26. NORTH AMERICAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY RESEARCH AREA, 2020-2027 ($ MILLION)
27. NORTH AMERICAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
28. EUROPEAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
29. EUROPEAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY SERVICE, 2020-2027 ($ MILLION)
30. EUROPEAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
31. EUROPEAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY RESEARCH AREA, 2020-2027 ($ MILLION)
32. EUROPEAN CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
33. ASIA-PACIFIC CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY COUNTRY, 2020-2027 ($ MILLION)
34. ASIA-PACIFIC CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY SERVICE, 2020-2027 ($ MILLION)
35. ASIA-PACIFIC CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
36. ASIA-PACIFIC CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY RESEARCH AREA, 2020-2027 ($ MILLION)
37. ASIA-PACIFIC CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
38. REST OF THE WORLD CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY SERVICE, 2020-2027 ($ MILLION)
39. REST OF THE WORLD CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY TYPE, 2020-2027 ($ MILLION)
40. REST OF THE WORLD CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY RESEARCH AREA, 2020-2027 ($ MILLION)
41. REST OF THE WORLD CUSTOM ANTIBODY MARKET RESEARCH AND ANALYSIS BY END-USER, 2020-2027 ($ MILLION)
1. IMPACT OF COVID-19 ON GLOBAL CUSTOM ANTIBODY MARKET, 2020-2027 ($ MILLION)
2. IMPACT OF COVID-19 ON GLOBAL CUSTOM ANTIBODY MARKET SHARE BY SEGMENT, 2020-2027 ($ MILLION)
3. RECOVERY OF GLOBAL CUSTOM ANTIBODY MARKET, 2021-2027 (%)
4. GLOBAL CUSTOM ANTIBODY MARKET SHARE BY SERVICE, 2020 VS 2027 (%)
5. GLOBAL CUSTOM ANTIBODY MARKET SHARE BY TYPE, 2020 VS 2027 (%)
6. GLOBAL CUSTOM ANTIBODY MARKET SHARE BY RESEARCH AREA, 2020 VS 2027 (%)
7. GLOBAL CUSTOM ANTIBODY MARKET SHARE BY END-USER, 2020 VS 2027 (%)
8. GLOBAL CUSTOM ANTIBODY MARKET SHARE BY GEOGRAPHY, 2020 VS 2027 (%)
9. GLOBAL ANTIBODY DEVELOPMENT MARKET BY REGION, 2020 VS 2027 (%)
10. GLOBAL ANTIBODY FRAGMENTATION & LABELING MARKET BY REGION, 2020 VS 2027 (%)
11. GLOBAL ANTIBODY PRODUCTION & PURIFICATION MARKET BY REGION, 2020 VS 2027 (%)
12. GLOBAL MONOCLONAL ANTIBODIES MARKET BY REGION, 2020 VS 2027 (%)
13. GLOBAL RECOMBINANT ANTIBODIES MARKET BY REGION, 2020 VS 2027 (%)
14. GLOBAL POLYCLONAL ANTIBODIES MARKET BY REGION, 2020 VS 2027 (%)
15. GLOBAL OTHER MARKET BY REGION, 2020 VS 2027 (%)
16. GLOBAL ONCOLOGY MARKET BY REGION, 2020 VS 2027 (%)
17. GLOBAL IMMUNOLOGY MARKET BY REGION, 2020 VS 2027 (%)
18. GLOBAL INFECTIOUS DISEASES MARKET BY REGION, 2020 VS 2027 (%)
19. GLOBAL NEUROBIOLOGY MARKET BY REGION, 2020 VS 2027 (%)
20. GLOBAL CARDIOVASCULAR DISEASES MARKET BY REGION, 2020 VS 2027 (%)
21. GLOBAL OTHER MARKET BY REGION, 2020 VS 2027 (%)
22. GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET BY REGION, 2020 VS 2027 (%)
23. GLOBAL ACADEMIC & RESEARCH INSTITUTES MARKET BY REGION, 2020 VS 2027 (%)
24. GLOBAL CONTRACT RESEARCH ORGANIZATIONS MARKET BY REGION, 2020 VS 2027 (%)
25. US CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
26. CANADA CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
27. UK CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
28. FRANCE CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
29. GERMANY CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
30. ITALY CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
31. SPAIN CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
32. REST OF EUROPE CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
33. INDIA CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
34. CHINA CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
35. JAPAN CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
36. SOUTH KOREA CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
37. REST OF ASIA-PACIFIC CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
38. REST OF THE WORLD CUSTOM ANTIBODY MARKET SIZE, 2020-2027 ($ MILLION)
